Acknowledgement
Supported by : 단국대학교
References
- Sim JG, Seo JK, Suh SJ. Prevalence and its changes of hepatitis B viral markers from 1988 to 1993 in Korean children. J Korean Pediatr Soc 1995;38:1535-8
- Szmuness W, Stevens CE, Harley EJ, Zang EA, Alter HJ, Taylor PE, et al. Hepatitis B vaccine in medical staff of hemodialysis units. N Engl J Med 1982;307:1481-6 https://doi.org/10.1056/NEJM198212093072403
- Crosnier J, Jungers P, Courouce AM, Laplanche A, Benhamou E, Degos F, et al. Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units : II, Haemodialysis patients. Lancet 1981;1:797-800
- Szmuness W, Stevens CE, Oleszko WR, Goodman A. Passive- active immunisation against hepatitis B : immunogenicity studies in adult Americans. Lancet 1981;1:575-7
- Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC, et al. Demonstration of efficacy in a controlled clinical trial in a high risk population in the United State. N Engl J Med 1980;303:833-41 https://doi.org/10.1056/NEJM198010093031501
- Guideline of Immunization, 5th ed. The Korean Pediatric Society 2002:57
- Hepatitis B virus : a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee(ACIP). MMWR Recomm Rep 1991;40:1-25
- Seto D, West DJ, Ioli VA. Persistence of antibody and immunologic memory in children immunized with hepatitis B vaccine at birth. Pediatr Infect Dis J 2002;21:793-5 https://doi.org/10.1097/00006454-200208000-00021
- Kim HW, Kim HS, Yang DO, Kim SJ. Immune responses of plasma derived HB vaccine for three years follow up. Korean J Med 1990;39:195-203
- Lee SJ, Han HK, Um MR, Choi KH, Lee MN, Yoo BH. Immune response to hepatitis B revaccination. Korean J Infect Dis 1996;28:59-66 https://doi.org/10.3109/00365549609027151
- Chang JY, Jeong SJ, Kim SK, Son BK, Hong YJ, Hong KS. Positive rate of HBsAg in school children in Incheon area. Korean J Pediatr Infect Dis 2003;10:153-8
- Kim CY. Immunoprophylaxis of hepatitis B. J Korean Med Assoc 1984;27:804-14
- Williams IT, Goldstein ST, Tufa J, TauilliiI S, Margolis HS, Mahoney FJ. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination. Pediatr Infect Dis J 2003;22:157-63
- Wu JS, Hwang LY, Goodman KJ, Beasley RP. Hepatitis B vaccination in high-risk infants : 10-year follow-up. J Infect Dis 1999;179:1319-25 https://doi.org/10.1086/314768
- Petersen KM, Bulkow LR, McMahon BJ, Zanis C, Getty M, Peters H, et al. Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth. Pediatr Infect Dis J 2004;23:650-5 https://doi.org/10.1097/01.inf.0000130952.96259.fd
- Lin YC, Chang MH, Ni YH, Hsu HY, Chen DS. Longterm immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. J Infect Dis 2003;187:134-8 https://doi.org/10.1086/345871
- Wainwright RB, McMahon BJ, Bulkow LR, Parkinson AJ, Harpster AP. Protection provided by hepatitis B vaccine in a Yupik Eskimo population. Seven-year results. Arch Intern Med 1991;151:1634-6 https://doi.org/10.1001/archinte.151.8.1634
- Banatvala J, Van Damme P, Oehen S. Lifelong protection against hepatitis B : the role of vaccine immunogenicity in immune memory. Vaccine 2000;19:877-85 https://doi.org/10.1016/S0264-410X(00)00224-3
- Poland GA, Jacobson RM. Prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med 2004;351:2832-8 https://doi.org/10.1056/NEJMcp041507
- Wainwright RB, Bulkow LR, Parkinson AJ, Zanis C, McMahon BJ. Protection provided by hepatitis B vaccine in a Yupik Eskimo population-result of a 10-year study. J Infect Dis 1997;175:674-7 https://doi.org/10.1093/infdis/175.3.674
- Ding L, Zhang M, Wang Y, Zhou S, Kong W, Smego RA Jr. A 9-year follow-up study of the immunogenicity and long-term efficacy of plasma-derived hepatitis B vaccine in high-risk Chinese neonates. Clin Infect Dis 1993;17:475-9 https://doi.org/10.1093/clinids/17.3.475
- Duval B, Gilca V, Boulianne N, De Wals P, Masse R, Trudeau G, et al. Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country. Pediatr Infect Dis J 2005;24:213-8 https://doi.org/10.1097/01.inf.0000154329.00361.39
- West DJ, Calandra GB. Vaccine induced immunologic memory for hepatitis B surface antigen : implications for policy on booster vaccination. Vaccine 1996;14:1019-27 https://doi.org/10.1016/0264-410X(96)00062-X
- European consensus group on hepatitis B immunity. Are booster immunization needed for lifelong hepatitis B immunity? Lancet 2000;355:561-5 https://doi.org/10.1016/S0140-6736(99)07239-6
- Waston BM, Di Prinzio S, West D. Persistence of hepatitis B antibody and anamnestic response to a booster dose in healthy adolescents and adults. Abstract 32, the 32nd National Immunization Conference : 1998 July 21-24; Atlanta, GA
- Lai CL, Lau JY, Yeoh EK, Chang WK, Lin HJ. Significance of isolated anti-HBc seropositivity by ELISA : implications and the role of radioimmunoassay. J Med Virol 1992;36:180-3 https://doi.org/10.1002/jmv.1890360306
- Aoki SK, Finegold D, Kuramoto IK, Douville C, Richards C, Randell R, et al. Significance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccine. Transfusion 1993;33: 362-7 https://doi.org/10.1046/j.1537-2995.1993.33593255593.x
- McIntyre A, Nimmo GR, Wood GM, Tinniswood RD, Kerlin P. Isolated hepatitis B core antibody - can response to hepatitis B vaccine help elucidate the cause- Aust N Z J Med 1992;22:19-22 https://doi.org/10.1111/j.1445-5994.1992.tb01703.x
- Williams JL, Christensen CJ, McMahon BJ, Bulkow LR, Cagle HH, Mayers JS, et al. Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers. Vaccine 2001;19:4081-5 https://doi.org/10.1016/S0264-410X(01)00112-8
- Lai CL, Wong BC, Yeoh EK, Lim WL, Chang WK, Lin HJ. Five-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasmaderived vaccine in children : immunogenicity and anamnestic responses. Hepatology 1993;18:763-7 https://doi.org/10.1002/hep.1840180403
- Epidemiology and prevention of vaccine-preventable diseases, 8th ed. Published by National Immunization Program, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. chapter 15. Hepatitis B. 2005:207
- West DJ, Watson B, Lichtman J, Hesley TM, Hedberg K. Persistence of immunologic memory for twelve years in children given hepatitis B vaccine in infancy. Pediatr Infect Dis J 1994;13:745-7 https://doi.org/10.1097/00006454-199408000-00015